title: Approach to the Highly Sensitized Kidney Transplant Candidate.
abstract: For patients with ESRD, kidney transplant offers significant survival and quality-of-life advantages compared with dialysis. But for patients seeking transplant who are highly sensitized, wait times have traditionally been long and options limited. The approach to the highly sensitized candidate for kidney transplant has changed substantially over time owing to new advances in desensitization, options for paired donor exchange (PDE), and changes to the deceased-donor allocation system. Initial evaluation should focus on determining living-donor availability because a compatible living donor is always the best option. However, for most highly sensitized candidates this scenario is unlikely. For candidates with an incompatible donor, PDE can improve the prospects of finding a compatible living donor but for many highly sensitized patients the probability of finding a match in the relatively small pools of donors in PDE programs is limited. Desensitization of a living donor/recipient pair with low levels of incompatibility is another reasonable approach. But for pairs with high levels of pathologic HLA antibodies, outcomes after desensitization for the patient and allograft are less optimal. Determining the degree of sensitization by calculated panel-reactive antibody (cPRA) is critical in counseling the highly sensitized patient on expected wait times to deceased-donor transplant. For candidates with a high likelihood of finding a compatible deceased donor in a reasonable time frame, waiting for a kidney is a good strategy. For the candidate without a living donor and with a low probability of finding a deceased-donor match, desensitization on the waiting list can be considered. The approach to the highly sensitized kidney transplant candidate must be individualized and requires careful discussion among the transplant center, patient, and referring nephrologist.
authors.affiliation: Division of Nephrology, University of Virginia, Charlottesville, Virginia dsk9s@virginia.edu.
authors.forename: Douglas S
authors.initials: DS
authors.lastname: Keith
authors.affiliation: Division of Nephrology, University of Virginia, Charlottesville, Virginia.
authors.forename: Gayle M
authors.initials: GM
authors.lastname: Vranic
mesh_terms: D000328:Adult; D000465:Algorithms; D003888:Desensitization, Immunologic; D006801:Humans; D007676:Kidney Failure, Chronic / Q000276:immunology* / Q000601:surgery*; D016030:Kidney Transplantation; D008297:Male
keywords: HLA antigens; allografts; chronic’ living donors; humans; immunology; kidney; kidney failure; kidney transplantation; quality of life; renal dialysis